Microfluidic platforms for modeling biological barriers in the circulatory system.

Area of Science:

• Biomedical Engineering
• Cell Biology
• Pharmacology

Background:

• Microfluidic platforms are increasingly used as in vitro models due to their ability to replicate complex microenvironments.
• They provide biochemical and biomechanical cues essential for modeling healthy and diseased organs.
• Conventional in vitro models lack the sophistication to fully recapitulate in vivo conditions.

Purpose of the Study:

• To review recent advancements in microfluidic platforms for modeling biological barriers.
• To highlight the suitability of microfluidics for simulating physiological conditions in organs.
• To discuss applications in disease progression, treatment studies, and pharmaceutical testing.

Main Methods:

• Review of current literature on microfluidic technologies for biological barrier modeling.
• Analysis of how microfluidic channel flow mimics blood and body fluid dynamics.
• Examination of microfluidic approaches applied to various organ barriers (lung, intestine, liver, kidney, brain, skin).

Main Results:

• Microfluidic platforms effectively recapitulate the microenvironments of biological barriers.
• The technology allows for the study of organ-level models for disease and treatment.
• Similar approaches can be used across different organ barriers for drug testing.

Conclusions:

• Microfluidic platforms represent a significant improvement over conventional in vitro models for studying biological barriers.
• These systems are valuable tools for understanding disease mechanisms and evaluating drug efficacy.
• The review underscores the potential of microfluidics in pharmaceutical research and development.